60-day FRN

0648-0433 60-day 85 FR 17314 2020-0327.pdf

Reporting Requirements for the Ocean Salmon Fishery off the Coasts of Washington, Oregon, and California

60-day FRN

OMB: 0648-0433

Document [pdf]
Download: pdf | pdf
17314

Federal Register / Vol. 85, No. 60 / Friday, March 27, 2020 / Notices

Comments may also be sent via fax to
(978) 465–3116 or submitted via email
to [email protected] with ‘‘DEIS for
Amendment 23 to the Northeast
Multispecies FMP’’ in the subject line.
Agenda
This hearing is the first of the series;
the remaining hearings will be
announced in a separate notice. Council
staff will brief the public on Draft
Amendment 23 before receiving
comments on the amendment. The
hearing will begin promptly at the time
indicated above. If all attendees who
wish to do so have provided their
comments prior to the end time
indicated, the hearing may conclude
early. To the extent possible, the
Council may extend hearings beyond
the end time indicated above to
accommodate all attendees who wish to
speak.
Although non-emergency issues not
contained on the agenda may come
before this Council for discussion, those
issues may not be the subject of formal
action during this hearing. Council
action will be restricted to those issues
specifically listed in this notice and any
issues arising after publication of this
notice that require emergency action
under section 305(c) of the MagnusonStevens Act, provided the public has
been notified of the Council’s intent to
take final action to address the
emergency. The public also should be
aware that the meeting will be recorded.
Consistent with 16 U.S.C. 1852, a copy
of the recording is available upon
request.
Special Accommodations
This hearing is physically accessible
to people with disabilities. Requests for
sign language interpretation or other
auxiliary aids should be directed to
Thomas A. Nies, Executive Director, at
(978) 465–0492, at least 5 days prior to
the meeting date.
Authority: 16 U.S.C. 1801 et seq.
Dated: March 24, 2020.
Tracey L. Thompson,
Acting Deputy Director, Office of Sustainable
Fisheries, National Marine Fisheries Service.
khammond on DSKJM1Z7X2PROD with NOTICES

[FR Doc. 2020–06423 Filed 3–26–20; 8:45 am]
BILLING CODE 3510–22–P

VerDate Sep<11>2014

16:28 Mar 26, 2020

Jkt 250001

DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
Proposed Information Collection;
Comment Request; Reporting
Requirements for the Ocean Salmon
Fishery Off the Coasts of Washington,
Oregon, and California
National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Notice.
AGENCY:

The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden, invites the general
public and other Federal agencies to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995.
DATES: To ensure consideration, written
or on-line comments must be submitted
on or before May 26, 2020.
ADDRESSES: Direct all written comments
to Adrienne Thomas, PRA Officer,
NOAA, 151 Patton Avenue, Room 159,
Asheville, NC 28801 (or via the internet
at [email protected]). All
comments received are part of the
public record. Comments will generally
be posted without change. All
Personally Identifiable Information (for
example, name and address) voluntarily
submitted by the commenter may be
publicly accessible. Do not submit
Confidential Business Information or
otherwise sensitive or protected
information.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
instrument and instructions should be
directed to Peggy Mundy, National
Marine Fisheries Service (NMFS) West
Coast Region, telephone: 206–526–4323;
email: [email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Abstract
This request is for an extension of a
currently approved information
collection.
Ocean salmon fisheries conducted in
the U.S. exclusive economic zone, 3–
200 nautical miles off the West Coast
states of Washington, Oregon, and
California are managed by the Pacific
Fishery Management Council (Council)
and NOAA’s National Marine Fisheries
Service (NMFS) under the Magnuson
Stevens Fishery Conservation and
Management Act (MSA). Management
measures for the ocean salmon fisheries
are set annually, consistent with the

PO 00000

Frm 00011

Fmt 4703

Sfmt 4703

Council’s Pacific Coast Salmon Fishery
Management Plan (FMP). The FMP
provides a framework for managing the
ocean salmon fisheries in a sustainable
manner, as required under the MSA,
through the use of conservation
objectives, annual catch limits, and
other reference points and status
determination criteria described in the
FMP. To meet these criteria, annual
management measures, published in the
Federal Register by NMFS, specify
regulatory areas, catch restrictions, and
landing restrictions based on the stock
abundance forecasts. These catch and
landing restrictions include area- and
species-specific quotas for the
commercial ocean salmon fishery, and
generally require landings to be reported
to the appropriate state agencies to
allow for a timely and accurate
accounting of the season’s catch (50 CFR
660.404 and 50 CFR 660.408(o)). The
best available catch and effort data and
projections are presented by the state
fishery managers in telephone
conference calls involving the NMFS
Northwest Regional Administrator and
representatives of the Council. However,
NMFS acknowledges that unsafe
weather or mechanical problems could
prevent commercial fishermen from
making their landings at the times and
places specified, and the MSA requires
conservation and management measures
to promote the safety of human life at
sea. Therefore, the annual management
measures will include provisions to
exempt commercial salmon fishermen
from compliance with the landing
requirements when they experience
unsafe weather conditions or
mechanical problems at sea, so long as
the appropriate notifications are made
by, for example, at-sea radio and
cellular telephone, and information on
catch and other required information is
given, under this collection of
information. The annual management
measures will specify the contents and
procedure of the notifications, and the
entities receiving the notifications (e.g.,
U.S. Coast Guard). Absent this
requirement by the Council, the state
reporting systems would not regularly
collect this specific type of in-season
radio report. These provisions, and this
federal collection of information,
promote safety at sea and provide
practical utility for sustainably
managing the fishery, ensuring
regulatory consistency across each state
by implementing the same requirements
for alternative reporting in unsafe
conditions in the surrounding territorial
waters. This information collection is
intended to be general in scope by
leaving the specifics of the notifications

E:\FR\FM\27MRN1.SGM

27MRN1

Federal Register / Vol. 85, No. 60 / Friday, March 27, 2020 / Notices
for annual determination, thus
providing flexibility in responding to
salmon management concerns in any
given year.

Notice of interim Patent term
extension.

ACTION:

II. Method of Collection
Notifications are made by at-sea radio
or cellular phone transmissions.
III. Data
OMB Control Number: 0648–0433.
Form Number(s): None.
Type of Review: Regular submission
(extension of a currently approved
collection).
Affected Public: Business or other forprofit organizations.
Estimated Number of Respondents:
40.
Estimated Time per Response: 15
minutes.
Estimated Total Annual Burden
Hours: 10 hours.
Estimated Total Annual Cost to
Public: $0 in recordkeeping/reporting
costs.
IV. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Comments submitted in response to
this notice will be summarized and/or
included in the request for OMB
approval of this information collection;
they also will become a matter of public
record.
Dated: March 24, 2020.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2020–06402 Filed 3–26–20; 8:45 am]
BILLING CODE 3510–22–P

khammond on DSKJM1Z7X2PROD with NOTICES

DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No.: PTO–P–2020–0019]

Grant of Interim Extension of the Term
of U.S. Patent No. 8,858,612; Reducer®
United States Patent and
Trademark Office, Commerce.

AGENCY:

VerDate Sep<11>2014

16:28 Mar 26, 2020

Jkt 250001

The United States Patent and
Trademark Office has issued an order
granting interim extension for a oneyear interim extension of the term of
U.S. Patent No. 8,858,612.
FOR FURTHER INFORMATION CONTACT: Ali
Salimi by telephone at (571) 272–0909;
by mail marked to his attention and
addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to his attention at
(571) 273–0909; or by email to
[email protected].
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On March 11, 2020, Neovasc Medical
Ltd., the patent owner of record, timely
filed an application under 35 U.S.C.
156(d)(5) for an interim extension of the
term of U.S. Patent No. 8,858,612. The
patent claims method of use of catheter
delivered implantable device, Reducer®.
The application for patent term
extension indicates that a Premarket
Approval Application (PMA) P190035
was submitted to the Food and Drug
Administration (FDA) on December 31,
2019.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the original
expiration date of the patent, March 27,
2020, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
8,858,612 is granted for a period of one
year from the original expiration date of
the patent.
SUMMARY:

Robert Bahr,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
[FR Doc. 2020–06447 Filed 3–26–20; 8:45 am]
BILLING CODE 3510–16–P

PO 00000

Frm 00012

Fmt 4703

Sfmt 4703

17315

DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2020–0020]

Grant of Interim Extension of the Term
of U.S. Patent No. 6,953,476; Reducer®
United States Patent and
Trademark Office, Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:

The United States Patent and
Trademark Office has issued an order
granting interim extension under 35
U.S.C. 156(d)(5) for a one-year interim
extension of the term of U.S. Patent No.
6,953,476.
FOR FURTHER INFORMATION CONTACT: Ali
Salimi by telephone at (571) 272–0909;
by mail marked to his attention and
addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to his attention at
(571) 273–0909; or by email to
[email protected].
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On March 11, 2020, Neovasc Medical
Ltd., the patent owner of record, timely
filed an application under 35 U.S.C.
156(d)(5) for an interim extension of the
term of U.S. Patent No. 6,953,476. The
patent claims a catheter delivered
implantable device, Reducer®. The
application for patent term extension
indicates that a Premarket Approval
Application (PMA) P190035 was
submitted to the Food and Drug
Administration (FDA) on December 31,
2019.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the original
expiration date of the patent, March 27,
2020, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
SUMMARY:

E:\FR\FM\27MRN1.SGM

27MRN1


File Typeapplication/pdf
File Modified2020-03-27
File Created2020-03-27

© 2024 OMB.report | Privacy Policy